The incorporation of cystine by the soluble carrier family 7 member 11 (SLC7A11) is a component of the redox regulatory mechanism in stallion spermatozoa†.

The research article mainly focuses on the role of the soluble carrier family 7 member 11 (SLC7A11) protein in stallion spermatozoa. It highlights the impact of these proteins on the redox regulation and motility of fresh and frozen-thawed sperm. It also provides new insights into the potential ways to improve sperm cryopreservation processes and male infertility treatments.

Presence of SLC7A11 in Stallion Spermatozoa

• The team of researchers describes the presence of the SLC7A11 antiporter, which is a protein that exchanges extracellular cystine (Cyss) for intracellular glutamate, in stallion spermatozoa.
• This is the first time such an occurrence has been noted.

Role of Cystine and Sulfasalazine

• When spermatozoa were incubated with Cyss, an increase in intracellular GSH content was observed when compared to controls—in fresh extended stallion spermatozoa, the increase was 50%, and in frozen-thawed spermatozoa it was 30%.
• The researcher used sulfasalazine, a specific inhibitor of SLC7A11, to observe its impact. Sulfasalazine prevented the increase in GSH content caused by Cyss.

Reduction-Oxidation Effect

• Cystine supplementation was found to reduce the oxidation-reduction potential of spermatozoa. This basically means that it helped to balance the oxidative properties and thereby regulated redox signaling and control mechanisms in spermatozoa.
• Sulfasalazine, however, only prevented this effect on fresh spermatozoa that were incubated for 3 hours at 37°C, but not in frozen-thawed spermatozoa.

Impact on Sperm Motility

• Sulfasalazine led to a decrease in the motility of frozen-thawed spermatozoa.
• In contrast, it was found to increase motility in fresh samples.

Implications for Male Infertility and Sperm Cryopreservation

• The findings can provide valuable insights into understanding the mechanism regulating the redox status of spermatozoa and help improve current sperm cryopreservation technologies.
• The research suggests a different redox regulatory mechanism operates in cryopreserved spermatozoa, potentially forming the basis for strategies to improve male infertility treatments.